We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+2.77%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$4.19B
AUM Growth
+$135M
Cap. Flow
+$49.5M
Cap. Flow %
1.18%
Top 10 Hldgs %
44.67%
Holding
487
New
37
Increased
209
Reduced
193
Closed
27

Sector Composition

Rank Sector Weight
1 Technology 13.7%
2 Healthcare 5.68%
3 Financials 4.5%
4 Communication Services 3.15%
5 Industrials 2.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DGRO icon
151
iShares Core Dividend Growth ETF
DGRO
$42.7B
$3.22M 0.08%
46,429
+662
+1% +$45.5K
MMM icon
152
3M
MMM
$90.9B
$3.16M 0.08%
19,714
+2,521
+15% +$412K
DHR icon
153
Danaher
DHR
$137B
$3.04M 0.07%
13,300
+5,599
+73% +$1.23M
VGT icon
154
Vanguard Information Technology ETF
VGT
$139B
$3.03M 0.07%
32,208
+3,872
+14% +$368K
EEM icon
155
iShares MSCI Emerging Markets ETF
EEM
$28.8B
$3.03M 0.07%
55,424
+474
+0.9% +$25.8K
BINC icon
156
BlackRock Flexible Income ETF
BINC
$16.1B
$3M 0.07%
56,802
-898
-2% -$47.7K
TJX icon
157
TJX Companies
TJX
$174B
$2.99M 0.07%
19,452
+2,108
+12% +$312K
FCOM icon
158
Fidelity MSCI Communication Services Index ETF
FCOM
$1.77B
$2.96M 0.07%
40,366
+19,165
+90% +$1.36M
STZ icon
159
Constellation Brands
STZ
$22.2B
$2.94M 0.07%
21,307
-4,604
-18% -$632K
LRGF icon
160
iShares US Equity Factor ETF
LRGF
$3.58B
$2.94M 0.07%
42,316
-230
-0.5% -$15.9K
IBB icon
161
iShares Biotechnology ETF
IBB
$9.34B
$2.93M 0.07%
17,386
-366
-2% -$59.4K
IDXX icon
162
Idexx Laboratories
IDXX
$44.1B
$2.92M 0.07%
4,317
-84
-2% -$57.2K
BSX icon
163
Boston Scientific
BSX
$69.5B
$2.88M 0.07%
30,208
+5,799
+24% +$569K
VTI icon
164
Vanguard Morningstar Total Stock Market ETF
VTI
$660B
$2.85M 0.07%
8,486
-229
-3% -$76.2K
CAT icon
165
Caterpillar
CAT
$375B
$2.83M 0.07%
4,940
+1,457
+42% +$810K
TD icon
166
Toronto Dominion Bank
TD
$198B
$2.81M 0.07%
29,860
+90
+0.3% +$7.6K
FTSL icon
167
First Trust Senior Loan Fund ETF
FTSL
$2.32B
$2.77M 0.07%
+60,455
New +$2.77M
MRK icon
168
Merck
MRK
$322B
$2.77M 0.07%
26,323
-596
-2% -$55.9K
ESGD icon
169
iShares ESG Aware MSCI EAFE ETF
ESGD
$12B
$2.69M 0.06%
28,333
+1,748
+7% +$165K
ORCL icon
170
Oracle
ORCL
$374B
$2.68M 0.06%
13,747
-4,068
-23% -$969K
VIG icon
171
Vanguard Dividend Appreciation ETF
VIG
$111B
$2.67M 0.06%
12,129
+603
+5% +$132K
IWN icon
172
iShares Russell 2000 Value ETF
IWN
$14.3B
$2.61M 0.06%
14,412
-1,347
-9% -$242K
SCHE icon
173
Schwab Emerging Markets Equity ETF
SCHE
$12.6B
$2.58M 0.06%
78,705
-2,476
-3% -$82.6K
KXI icon
174
iShares Global Consumer Staples ETF
KXI
$1.07B
$2.49M 0.06%
+38,526
New +$2.5M
IWD icon
175
iShares Russell 1000 Value ETF
IWD
$82.2B
$2.48M 0.06%
11,804
+15
+0.1% +$3.1K

Similar funds

Grimes & Company's Q4 2025 Portfolio in Review

As of Q4 2025, Grimes & Company held 487 positions worth $4.19B, up 3.3% from $4.05B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Grimes & Company's Q4 2025 filing shows 37 new, 209 increased, 193 reduced and 27 closed positions. Its largest new stake was iShares 0-3 Month Treasury Bond ETF: 190,372 shares worth $19.1M. The largest sale was State Street Materials Select Sector SPDR ETF, an estimated $20.5M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Financials.

  • Grimes & Company's largest Q4 2025 buy was iShares 0-3 Month Treasury Bond ETF: 190,372 shares worth $19.1M.
  • Grimes & Company added most to State Street Health Care Select Sector SPDR ETF in Q4 2025, an estimated $35.7M increase.
  • Grimes & Company's biggest Q4 2025 reduction was Invesco S&P 500 Equal Weight ETF, cutting an estimated $14.7M.
  • Grimes & Company fully exited State Street Materials Select Sector SPDR ETF in Q4 2025, selling an estimated $20.5M.
  • Grimes & Company's ten largest holdings make up 45% of its $4.19B portfolio in Q4 2025.
  • Grimes & Company opened 37 new positions and closed 27 in Q4 2025.
  • Grimes & Company's portfolio value rose 3.3% quarter-over-quarter to $4.19B.

Based on Grimes & Company's 13F filing for Q4 2025, filed 3 Feb 2026.